CAM
PASG icon

Cresset Asset Management’s Passage Bio PASG Stock Holding History

Cresset Asset Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,186
Closed -$16.6K – 2084
2024
Q3 		$16.6K Hold
1,186
– – ﹤0.01% 2146
2024
Q2 		$18.8K Hold
1,186
– – ﹤0.01% 2053
2024
Q1 		$32K Hold
1,186
– – ﹤0.01% 1871
2023
Q4 		$24K Hold
1,186
– – ﹤0.01% 1812
2023
Q3 		$15.6K Hold
1,186
– – ﹤0.01% 1781
2023
Q2 		$22.3K Buy
+1,186
New +$23.5K ﹤0.01% 1873

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cresset Asset Management's PASG Position: Q4 2024 in Review

Cresset Asset Management sold out of Passage Bio (PASG) in Q4 2024, closing a stake of 1,186 shares — an estimated $16.6K sold.

Cresset Asset Management first reported a position in PASG in Q2 2023 and held it in 6 quarters. The position peaked at $32K in Q1 2024. 44 funds tracked by Wall St. Rank hold PASG as of Q4 2024.

  • Cresset Asset Management reported no remaining Passage Bio position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 1,186 Passage Bio shares in Q4 2024, an estimated $16.6K.
  • Cresset Asset Management first reported a position in Passage Bio in Q2 2023 and held it in 6 quarters.
  • Cresset Asset Management's Passage Bio position peaked at $32K in Q1 2024.
  • 44 funds tracked by Wall St. Rank held Passage Bio as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.